Risk of severe herpes simplex virus infection in systemic lupus erythematosus: Analysis of epidemiology and risk factors analysis in Taiwan

Tzu Hao Li, Chien Chih Lai, Wen Hsiu Wang, Wei Sheng Chen, Yen Po Tsao, Chang Youh Tsai, Yu Sheng Chang

Research output: Contribution to journalArticle

Abstract

Objective: Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis. However, few attempts to analyse the associated incidence and risk factors have been made. Methods: We enrolled patients with SLE recorded between 1997 and 2012 and compared the incidence rate (IR) of severe HSV infection, including meningoencephalitis, septicaemia, ocular and visceral involvement, and other specific complications demanding hospitalisation, with that of a non-SLE cohort. A Cox multivariate proportional hazards model was applied to analyse the risk factors of severe HSV infection in patients with SLE. Results: A total of 122 520 subjects (24 504 patients with SLE and 98 016 age-matched and sex-matched non-SLE controls) were included, and a higher IR of severe HSV infection was revealed in the SLE group (IR ratio=3.93, p<0.001). In patients with SLE, previous oral and genital infection (HR=2.29, p=0.049), intravenous steroid pulse therapy (HR=5.32, p<0.001) and daily oral dose of over 7.5 mg of prednisolone (HR=1.59, p=0.024) were independent risk factors for severe HSV infection, whereas age of ≤18 (HR=0.45, p=0.029) was a protective factor. Conclusions: Patients with SLE are at higher risk of severe HSV infection, and related risk factors include being older than 18 years, having a history of HSV mucocutaneous infection, recent receipt of steroid pulse therapy and a daily oral dose of steroid over 7.5 mg prednisolone.

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Epidemiology
Virus Diseases
Factor analysis
Simplexvirus
Taiwan
Viruses
Systemic Lupus Erythematosus
Statistical Factor Analysis
Meningoencephalitis
Steroids
Incidence
Prednisolone
Keratitis
Proportional Hazards Models
Sepsis
Hazards
Hospitalization
Therapeutics
Infection

Keywords

  • herpes simplex virus
  • keratitis
  • meningoencephalitis
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Risk of severe herpes simplex virus infection in systemic lupus erythematosus : Analysis of epidemiology and risk factors analysis in Taiwan. / Li, Tzu Hao; Lai, Chien Chih; Wang, Wen Hsiu; Chen, Wei Sheng; Tsao, Yen Po; Tsai, Chang Youh; Chang, Yu Sheng.

In: Annals of the Rheumatic Diseases, 01.01.2019.

Research output: Contribution to journalArticle

@article{2f75d9b16fb54b6da735a43de7b4fa7f,
title = "Risk of severe herpes simplex virus infection in systemic lupus erythematosus: Analysis of epidemiology and risk factors analysis in Taiwan",
abstract = "Objective: Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis. However, few attempts to analyse the associated incidence and risk factors have been made. Methods: We enrolled patients with SLE recorded between 1997 and 2012 and compared the incidence rate (IR) of severe HSV infection, including meningoencephalitis, septicaemia, ocular and visceral involvement, and other specific complications demanding hospitalisation, with that of a non-SLE cohort. A Cox multivariate proportional hazards model was applied to analyse the risk factors of severe HSV infection in patients with SLE. Results: A total of 122 520 subjects (24 504 patients with SLE and 98 016 age-matched and sex-matched non-SLE controls) were included, and a higher IR of severe HSV infection was revealed in the SLE group (IR ratio=3.93, p<0.001). In patients with SLE, previous oral and genital infection (HR=2.29, p=0.049), intravenous steroid pulse therapy (HR=5.32, p<0.001) and daily oral dose of over 7.5 mg of prednisolone (HR=1.59, p=0.024) were independent risk factors for severe HSV infection, whereas age of ≤18 (HR=0.45, p=0.029) was a protective factor. Conclusions: Patients with SLE are at higher risk of severe HSV infection, and related risk factors include being older than 18 years, having a history of HSV mucocutaneous infection, recent receipt of steroid pulse therapy and a daily oral dose of steroid over 7.5 mg prednisolone.",
keywords = "herpes simplex virus, keratitis, meningoencephalitis, systemic lupus erythematosus",
author = "Li, {Tzu Hao} and Lai, {Chien Chih} and Wang, {Wen Hsiu} and Chen, {Wei Sheng} and Tsao, {Yen Po} and Tsai, {Chang Youh} and Chang, {Yu Sheng}",
year = "2019",
month = "1",
day = "1",
doi = "10.1136/annrheumdis-2018-214844",
language = "English",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Risk of severe herpes simplex virus infection in systemic lupus erythematosus

T2 - Analysis of epidemiology and risk factors analysis in Taiwan

AU - Li, Tzu Hao

AU - Lai, Chien Chih

AU - Wang, Wen Hsiu

AU - Chen, Wei Sheng

AU - Tsao, Yen Po

AU - Tsai, Chang Youh

AU - Chang, Yu Sheng

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis. However, few attempts to analyse the associated incidence and risk factors have been made. Methods: We enrolled patients with SLE recorded between 1997 and 2012 and compared the incidence rate (IR) of severe HSV infection, including meningoencephalitis, septicaemia, ocular and visceral involvement, and other specific complications demanding hospitalisation, with that of a non-SLE cohort. A Cox multivariate proportional hazards model was applied to analyse the risk factors of severe HSV infection in patients with SLE. Results: A total of 122 520 subjects (24 504 patients with SLE and 98 016 age-matched and sex-matched non-SLE controls) were included, and a higher IR of severe HSV infection was revealed in the SLE group (IR ratio=3.93, p<0.001). In patients with SLE, previous oral and genital infection (HR=2.29, p=0.049), intravenous steroid pulse therapy (HR=5.32, p<0.001) and daily oral dose of over 7.5 mg of prednisolone (HR=1.59, p=0.024) were independent risk factors for severe HSV infection, whereas age of ≤18 (HR=0.45, p=0.029) was a protective factor. Conclusions: Patients with SLE are at higher risk of severe HSV infection, and related risk factors include being older than 18 years, having a history of HSV mucocutaneous infection, recent receipt of steroid pulse therapy and a daily oral dose of steroid over 7.5 mg prednisolone.

AB - Objective: Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis. However, few attempts to analyse the associated incidence and risk factors have been made. Methods: We enrolled patients with SLE recorded between 1997 and 2012 and compared the incidence rate (IR) of severe HSV infection, including meningoencephalitis, septicaemia, ocular and visceral involvement, and other specific complications demanding hospitalisation, with that of a non-SLE cohort. A Cox multivariate proportional hazards model was applied to analyse the risk factors of severe HSV infection in patients with SLE. Results: A total of 122 520 subjects (24 504 patients with SLE and 98 016 age-matched and sex-matched non-SLE controls) were included, and a higher IR of severe HSV infection was revealed in the SLE group (IR ratio=3.93, p<0.001). In patients with SLE, previous oral and genital infection (HR=2.29, p=0.049), intravenous steroid pulse therapy (HR=5.32, p<0.001) and daily oral dose of over 7.5 mg of prednisolone (HR=1.59, p=0.024) were independent risk factors for severe HSV infection, whereas age of ≤18 (HR=0.45, p=0.029) was a protective factor. Conclusions: Patients with SLE are at higher risk of severe HSV infection, and related risk factors include being older than 18 years, having a history of HSV mucocutaneous infection, recent receipt of steroid pulse therapy and a daily oral dose of steroid over 7.5 mg prednisolone.

KW - herpes simplex virus

KW - keratitis

KW - meningoencephalitis

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85064007563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064007563&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2018-214844

DO - 10.1136/annrheumdis-2018-214844

M3 - Article

AN - SCOPUS:85064007563

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

ER -